Our results showed that tumors from mice treated with Dl1.72 presented a significant decrease of proliferating tumor cells (approximately 60% reduction of Ki67+ cells) in comparison to tumors from control mice treated with PBS or Ctr Ab (Figure 6a,b). The gene discussed is MKI67; the disease is neoplasm.